265 related articles for article (PubMed ID: 15857134)
21. Design of novel chimeric melanotropin-deltorphin analogues. Discovery of the first potent human melanocortin 1 receptor antagonist.
Han G; Quillan JM; Carlson K; Sadée W; Hruby VJ
J Med Chem; 2003 Feb; 46(5):810-9. PubMed ID: 12593660
[TBL] [Abstract][Full Text] [Related]
22. Design of low molecular weight hematoregulatory agents from the structure-activity relationship of a dimeric pentapeptide.
Cuthbertson AS; Husbyn M; Engebretsen M; Hartmann M; Lange M; Sandosham J; Fischer PM; Fjerdingstad H; Løvhaug D
J Med Chem; 1997 Aug; 40(18):2876-82. PubMed ID: 9288169
[TBL] [Abstract][Full Text] [Related]
23. Discovery of a new class of macrocyclic antagonists to the human motilin receptor.
Marsault E; Hoveyda HR; Peterson ML; Saint-Louis C; Landry A; Vézina M; Ouellet L; Wang Z; Ramaseshan M; Beaubien S; Benakli K; Beauchemin S; Déziel R; Peeters T; Fraser GL
J Med Chem; 2006 Nov; 49(24):7190-7. PubMed ID: 17125271
[TBL] [Abstract][Full Text] [Related]
24. Biological diversity from a structurally diverse library: systematically scanning conformational space using a pyranose scaffold.
Abbenante G; Becker B; Blanc S; Clark C; Condie G; Fraser G; Grathwohl M; Halliday J; Henderson S; Lam A; Liu L; Mann M; Muldoon C; Pearson A; Premraj R; Ramsdale T; Rossetti T; Schafer K; Le Thanh G; Tometzki G; Vari F; Verquin G; Waanders J; West M; Wimmer N; Yau A; Zuegg J; Meutermans W
J Med Chem; 2010 Aug; 53(15):5576-86. PubMed ID: 20684600
[TBL] [Abstract][Full Text] [Related]
25. Restriction of a peptide turn conformation and conformational analysis of guanidino group using arginine-proline fused amino acids: application to mini atrial natriuretic peptide on binding to the receptor.
Sugase K; Horikawa M; Sugiyama M; Ishiguro M
J Med Chem; 2004 Jan; 47(2):489-92. PubMed ID: 14711318
[TBL] [Abstract][Full Text] [Related]
26. 1H-NMR studies on a potent and selective antagonist at human melanocortin receptor 4 (hMC-4R).
Victoria Silva Elipe M; Mosley RT; Bednarek MA; Arison BH
Biopolymers; 2003 Apr; 68(4):512-27. PubMed ID: 12666176
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationship studies of the aromatic positions in cyclopentapeptide CXCR4 antagonists.
Mungalpara J; Zachariassen ZG; Thiele S; Rosenkilde MM; Våbenø J
Org Biomol Chem; 2013 Dec; 11(47):8202-8. PubMed ID: 24150741
[TBL] [Abstract][Full Text] [Related]
28. Cyclic peptide analysis of the biologically active loop region in the laminin alpha3 chain LG4 module demonstrates the importance of peptide conformation on biological activity.
Kato-Takagaki K; Suzuki N; Yokoyama F; Takaki S; Umezawa K; Higo J; Mochizuki M; Kikkawa Y; Oishi S; Utani A; Nomizu M
Biochemistry; 2007 Feb; 46(7):1952-60. PubMed ID: 17261031
[TBL] [Abstract][Full Text] [Related]
29. Discovery of novel, highly potent and selective beta-hairpin mimetic CXCR4 inhibitors with excellent anti-HIV activity and pharmacokinetic profiles.
DeMarco SJ; Henze H; Lederer A; Moehle K; Mukherjee R; Romagnoli B; Robinson JA; Brianza F; Gombert FO; Lociuro S; Ludin C; Vrijbloed JW; Zumbrunn J; Obrecht JP; Obrecht D; Brondani V; Hamy F; Klimkait T
Bioorg Med Chem; 2006 Dec; 14(24):8396-404. PubMed ID: 17010618
[TBL] [Abstract][Full Text] [Related]
30. Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.
Albizu L; Teppaz G; Seyer R; Bazin H; Ansanay H; Manning M; Mouillac B; Durroux T
J Med Chem; 2007 Oct; 50(20):4976-85. PubMed ID: 17850055
[TBL] [Abstract][Full Text] [Related]
31. Thioether side chain cyclization for helical peptide formation: inhibitors of estrogen receptor-coactivator interactions.
Galande AK; Bramlett KS; Burris TP; Wittliff JL; Spatola AF
J Pept Res; 2004 Mar; 63(3):297-302. PubMed ID: 15049842
[TBL] [Abstract][Full Text] [Related]
32. Geometric diversity through permutation of backbone configuration in cyclic peptide libraries.
Perlman ZE; Bock JE; Peterson JR; Lokey RS
Bioorg Med Chem Lett; 2005 Dec; 15(23):5329-34. PubMed ID: 16213707
[TBL] [Abstract][Full Text] [Related]
33. A metal-free DNA nuclease based on a cyclic peptide scaffold.
Alkhader S; Ezra A; Kasparkova J; Brabec V; Yavin E
Bioconjug Chem; 2010 Aug; 21(8):1425-31. PubMed ID: 20715847
[TBL] [Abstract][Full Text] [Related]
34. Potent and selective agonists of human melanocortin receptor 5: cyclic analogues of alpha-melanocyte-stimulating hormone.
Bednarek MA; MacNeil T; Tang R; Fong TM; Cabello MA; Maroto M; Teran A
J Med Chem; 2007 May; 50(10):2520-6. PubMed ID: 17455928
[TBL] [Abstract][Full Text] [Related]
35. Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity.
March DR; Proctor LM; Stoermer MJ; Sbaglia R; Abbenante G; Reid RC; Woodruff TM; Wadi K; Paczkowski N; Tyndall JD; Taylor SM; Fairlie DP
Mol Pharmacol; 2004 Apr; 65(4):868-79. PubMed ID: 15044616
[TBL] [Abstract][Full Text] [Related]
36. Design of benzophenone-containing photoactivatable linear vasopressin antagonists: pharmacological and photoreactive properties.
Ponthieux S; Cabot J; Mouillac B; Seyer R; Barberis C; Carnazzi E
J Med Chem; 2005 May; 48(9):3379-88. PubMed ID: 15857144
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and biological evaluation of new cyclic disulfide decapeptides that inhibit the binding of AP-1 to DNA.
Tsuchida K; Chaki H; Takakura T; Yokotani J; Aikawa Y; Shiozawa S; Gouda H; Hirono S
J Med Chem; 2004 Aug; 47(17):4239-46. PubMed ID: 15293995
[TBL] [Abstract][Full Text] [Related]
38. Examination of methodology for the synthesis of cyclic thioether peptide libraries derived from linear tripeptides.
Roberts KD; Ede NJ
J Pept Sci; 2007 Dec; 13(12):811-21. PubMed ID: 17880033
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and pharmacological evaluation of cyclic mimetics of the insulin-like peptide 3 (INSL3) B-chain.
Shabanpoor F; Bathgate RA; Hossain MA; Giannakis E; Wade JD; Hughes RA
J Pept Sci; 2007 Feb; 13(2):113-20. PubMed ID: 17120268
[TBL] [Abstract][Full Text] [Related]
40. Recognized sequence and conformation in design of linear peptides as a competitive inhibitor for HMG-CoA reductase.
Pak VV; Koo M; Yun L; Kwon DY
J Mol Recognit; 2007; 20(3):197-203. PubMed ID: 17486664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
